Co-Authors
This is a "connection" page, showing publications co-authored by Zheng-Li Shi and Zhiming Yuan.
Connection Strength
0.934
-
Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates. Virol Sin. 2021 Oct; 36(5):879-889.
Score: 0.235
-
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques. Cell Res. 2020 08; 30(8):670-677.
Score: 0.223
-
Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays. Virol Sin. 2012 Oct; 27(5):273-7.
Score: 0.130
-
Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2. Cell Discov. 2021 Aug 25; 7(1):74.
Score: 0.060
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18 years or older: A randomized, double-blind, placebo-controlled, phase 1/2 trial. EClinicalMedicine. 2021 Aug; 38:101010.
Score: 0.060
-
Biochemical and antigenic characterization of the structural proteins and their post-translational modifications in purified SARS-CoV-2 virions of an inactivated vaccine candidate. Emerg Microbes Infect. 2020 Dec; 9(1):2653-2662.
Score: 0.057
-
Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models. Emerg Microbes Infect. 2020 Dec; 9(1):2606-2618.
Score: 0.057
-
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. JAMA. 2020 09 08; 324(10):951-960.
Score: 0.056
-
A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles. Cell Res. 2020 11; 30(11):1046-1048.
Score: 0.056